Read about a combination drug screening platform, new fellowship position, collaboration that will help scientists develop better tissue models using 3-D printing technology, and more.
Collaborators from NCATS and NCI published a study demonstrating the system’s power to find drug combinations to treat a type of blood cancer.
Stephen C. Groft, Pharm.D., director of the Office of Rare Diseases Research at NCATS, retires on Feb. 8, 2014, after a distinguished career serving the needs of rare disease patients and families.
Get the Center’s latest news, announcements and funding opportunities delivered directly to your inbox.
How is NCATS advancing translational research? Learn more about the Center's work and some of its early successes.
MORE CENTER NEWS
Director discusses how NCATS serves as a catalyst for translational science.
Stem Cell Research & Therapy journal features introduction and reviews for 18 projects.
IN THE SPOTLIGHT
Rare Diseases Research Advocate Retires
Long-time rare diseases research champion Stephen C. Groft, Pharm.D., director of the NCATS Office of Rare Diseases Research, announced his retirement effective Feb. 8, 2014. Learn more about Groft’s legacy advocating for the needs of rare disease patients and families.